Literature DB >> 9723232

Study of neoral kinetics in adult renal transplantation treated with diltiazem.

S Mezzano1, C Flores, L Ardiles, A Foradori, A Elberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9723232     DOI： 10.1016/s0041-1345(98)00381-9

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Diltiazem augments the influence of MDR1 genotype status on cyclosporine concentration in Chinese patients with renal transplantation.

Authors:  Yi-xi Wang; Jia-li Li; Xue-ding Wang; Yu Zhang; Chang-xi Wang; Min Huang
Journal:  Acta Pharmacol Sin       Date:  2015-04-20       Impact factor: 6.150

Review 2.  Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.

Authors:  C J Dunn; A J Wagstaff; C M Perry; G L Plosker; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.

Authors:  Yixi Wang; Changxi Wang; Jiali Li; Xueding Wang; Genglong Zhu; Xiao Chen; Huichang Bi; Min Huang
Journal:  Eur J Clin Pharmacol       Date:  2008-10-21       Impact factor: 2.953

4.  Diltiazem on tacrolimus exposure and dose sparing in Chinese pediatric primary nephrotic syndrome: impact of CYP3A4, CYP3A5, ABCB1, and SLCO1B3 polymorphisms.

Authors:  Junyan Wang; Lingfei Huang; Peng Gao; Yan Hu; Yinghua Ni; Zhengyi Zhu; Liwen Zhang; Jufei Yang; Huifen Zhang; Luo Fang
Journal:  Eur J Clin Pharmacol       Date:  2020-08-15       Impact factor: 2.953

Review 5.  Antihypertensive treatment for kidney transplant recipients.

Authors:  Nicholas B Cross; Angela C Webster; Philip Masson; Philip J O'Connell; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.